Last update 23 Jan 2025

Hikma Pharma Ltd.

Subsidiary Company|
United Kingdom

Overview

Tags

Congenital Disorders
Nervous System Diseases
Hemic and Lymphatic Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Hemic and Lymphatic Diseases1
Nervous System Diseases1
Top 5 Drug TypeCount
Small molecule drug1
Top 5 TargetCount
thrombin(Factor IIa)1

Related

1
Drugs associated with Hikma Pharma Ltd.
Argatroban
Target
thrombin
Mechanism
thrombin inhibitors
Active Org.
Sandoz, Inc. [+9]
Originator Org.
Mitsubishi Tanabe Pharma Corp.Mitsubishi Tanabe Pharma Corp.
Active Indication
Heparin-induced thrombocytopenia and thrombosis [+8]
Inactive Indication
Angina, Unstable
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
Japan
First Approval Date16 Apr 1996
1
Clinical Trials associated with Hikma Pharma Ltd.
NCT02529787
/ CompletedPhase 1
Comparative Open-label,Randomized, Fasting, Single Dose, Two-way Crossover Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg DR Capsules (Takeda Pharmaceuticals America Inc., USA)
100 Clinical Results associated with Hikma Pharma Ltd.
Login to view more data
0 Patents (Medical) associated with Hikma Pharma Ltd.
Login to view more data
100 Deals associated with Hikma Pharma Ltd.
Login to view more data
100 Translational Medicine associated with Hikma Pharma Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 21 Apr 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Argatroban
 ( thrombin )		Thrombocytopenia
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free